Nutex Health (NASDAQ:NUTX – Free Report) had its price target boosted by Maxim Group from $45.00 to $50.00 in a report issued on Tuesday morning, Marketbeat Ratings reports. Maxim Group currently has a buy rating on the stock.
Separately, Benchmark raised their price target on Nutex Health from $30.00 to $45.00 and gave the company a “buy” rating in a research report on Wednesday, August 21st.
Get Our Latest Analysis on NUTX
Nutex Health Price Performance
Insider Transactions at Nutex Health
In related news, CFO Jon Christian Bates bought 1,350 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The stock was purchased at an average cost of $21.46 per share, for a total transaction of $28,971.00. Following the purchase, the chief financial officer now directly owns 2,277 shares in the company, valued at $48,864.42. This trade represents a 100.00 % increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 38.52% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Nutex Health
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. International Assets Investment Management LLC acquired a new stake in shares of Nutex Health during the 3rd quarter worth approximately $188,000. Thompson Davis & CO. Inc. acquired a new position in shares of Nutex Health in the third quarter valued at $494,000. Finally, Essex Investment Management Co. LLC bought a new position in Nutex Health in the third quarter worth $1,579,000. 5.32% of the stock is currently owned by institutional investors.
About Nutex Health
Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.
Read More
- Five stocks we like better than Nutex Health
- Investing In Preferred Stock vs. Common Stock
- Home Depot Stock: Targeting 12% in 2024 and 25% More in 2025
- Where Do I Find 52-Week Highs and Lows?
- Is Tesla’s Valuation a Bubble or Backed by Real Growth?
- What are earnings reports?
- Trucking Stocks Led the Pack Last Week: Can They Keep Rolling?
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.